免疫检查点疗法的未来

Sharma 等人（Thu，）研究了这个问题。

www.synapsesocial.com/papers/69d88ded52654bb436d19494 — DOI: https://doi.org/10.1126/science.aaa8172

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. LAG-3, a novel lymphocyte activation gene closely related to CD4.· 1990 · 922 citations
2. Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC).· 2014 · 231 citations
3. Phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC).· 2014 · 139 citations
4. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.· 1992 · 583 citations
5. VISTA Regulates the Development of Protective Antitumor Immunity· 2014 · 479 citations